Меланома Результаты клинических исследований
-
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and Aft
-
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has
-
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafe
-
Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage
-
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or M
-
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizuma
-
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot B
-
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
-
A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma
-
A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
-
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
-
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Mel
-
Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
-
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alter
-
Family Lifestyles, Actions, and Risk Education Intervention: Version 2
Исследования по заболеваниям
Рак лёгкогоНемелкоклеточный рак лёгкогоРак молочной железыКолоректальный ракРак желудкаРак печениРак поджелудочной железыРак простатыРак яичниковМеланомаЛейкозЛимфомаМножественная миеломаГлиобластомаДиабет 2 типаОжирениеГипертонияСердечная недостаточностьФибрилляция предсердийИнсультХроническая болезнь почекНАСГБолезнь АльцгеймераБолезнь ПаркинсонаРассеянный склерозДепрессияЭпилепсияБАСРевматоидный артритПсориазАтопический дерматитБолезнь КронаЯзвенный колитВолчанкаАстмаХОБЛ